Patents by Inventor Alberto Reiner

Alberto Reiner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF NORMALIZING AMINO ACID METABOLISM
    Publication number: 20230321021
    Abstract: Methods of normalizing amino acid metabolism in subjects on restricted protein diets and supplemental amino acids, using specially formulated amino acids that mimic the absorption and metabolism of naturally occurring proteins, are described.
    Type: Application
    Filed: May 31, 2023
    Publication date: October 12, 2023
    Applicant: APR Applied Pharma Research S.A.
    Inventors: Alberto REINER, Giorgio REINER
  • BIOAVAILABLE SUGAR-BASED DICLOFENAC FORMULATIONS
    Publication number: 20230233494
    Abstract: Ready to use liquid formulations of diclofenac potassium are disclosed which are particularly well suited for packaging in stick-packs.
    Type: Application
    Filed: June 8, 2021
    Publication date: July 27, 2023
    Applicant: APR Applied Pharma Research SA
    Inventors: Alberto REINER, Giorgio REINER
  • Methods of normalizing amino acid metabolism
    Patent number: 11701335
    Abstract: Methods of normalizing amino acid metabolism in subjects on restricted protein diets and supplemental amino acids, using specially formulated amino acids that mimic the absorption and metabolism of naturally occurring proteins, are described.
    Type: Grant
    Filed: August 16, 2019
    Date of Patent: July 18, 2023
    Assignee: APR Applied Pharma Research s.a.
    Inventors: Alberto Reiner, Giorgio Reiner
  • MODIFIED RELEASE ORALLY ADMINISTERED AMINO ACID FORMULATIONS
    Publication number: 20220347142
    Abstract: Methods and formulations of modified release amino acids are provided for the treatment or management of diseases defined by impaired amino acid metabolism, with improved pharmacokinetics, metabolism and utilization.
    Type: Application
    Filed: April 27, 2022
    Publication date: November 3, 2022
    Applicant: APR APPLIED PHARMA RESEARCH S.A.
    Inventors: Alberto REINER, Giorgio REINER
  • Modified release orally administered amino acid formulations
    Patent number: 11419837
    Abstract: Methods and formulations of modified release amino acids are provided for the treatment or management of diseases defined by impaired amino acid metabolism, with improved pharmacokinetics, metabolism and utilization.
    Type: Grant
    Filed: September 27, 2016
    Date of Patent: August 23, 2022
    Assignee: APR Applied Pharma Research S.A.
    Inventors: Alberto Reiner, Giorgio Reiner
  • READY TO USE DICLOFENAC STICK PACKS
    Publication number: 20220218606
    Abstract: Ready to use liquid formulations of diclofenac potassium are disclosed which are particularly well suited for packaging in stick-packs.
    Type: Application
    Filed: January 25, 2022
    Publication date: July 14, 2022
    Inventors: Alberto REINER, Giorgio REINER
  • Ready to use diclofenac stick packs
    Patent number: 11260026
    Abstract: Ready to use liquid formulations of diclofenac potassium are disclosed which are particularly well suited for packaging in stick-packs.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: March 1, 2022
    Assignee: APR Applied Pharma Research SA
    Inventors: Alberto Reiner, Giorgio Reiner
  • SUBSTANTIALLY SODIUM FREE DICLOFENAC POTASSIUM ORAL SOLUTIONS
    Publication number: 20220054440
    Abstract: Provided are orally formulations of diclofenac potassium with improved stability in response to cold conditions, and excellent taste and palatability.
    Type: Application
    Filed: August 31, 2021
    Publication date: February 24, 2022
    Inventors: Giorgio REINER, Alberto REINER, Paola MAFFEI
  • Substantially sodium free diclofenac potassium oral solutions
    Patent number: 11123318
    Abstract: Provided are orally formulations of diclofenac potassium with improved stability in response to cold conditions, and excellent taste and palatability.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: September 21, 2021
    Assignee: APR Applied Pharma Research S.A.
    Inventors: Giorgio Reiner, Alberto Reiner, Paola Maffei
  • DICLOFENAC FORMULATIONS AND METHODS OF USE
    Publication number: 20200323776
    Abstract: Methods and formulations are provided for treating migraine and other acute pain episodes using diclofenac, and formulations of diclofenac that provide both rapid and sustained relief from acute pain. Methods and formulations are also provided for treating symptoms that often accompany migraine and acute pain such as photophobia, phonophobia, nausea and vomiting.
    Type: Application
    Filed: December 17, 2019
    Publication date: October 15, 2020
    Inventors: Giorgio Reiner, Alberto Reiner
  • READY TO USE DICLOFENAC STICK PACKS
    Publication number: 20200197302
    Abstract: Ready to use liquid formulations of diclofenac potassium are disclosed which are particularly well suited for packaging in stick-packs.
    Type: Application
    Filed: December 13, 2019
    Publication date: June 25, 2020
    Inventors: Alberto Reiner, Giorgio Reiner
  • SUBSTANTIALLY SODIUM FREE DICLOFENAC POTASSIUM ORAL SOLUTIONS
    Publication number: 20200093772
    Abstract: Provided are orally formulations of diclofenac potassium with improved stability in response to cold conditions, and excellent taste and palatability.
    Type: Application
    Filed: July 30, 2019
    Publication date: March 26, 2020
    Inventors: Giorgio Reiner, Alberto Reiner, Paola Maffei
  • METHODS OF NORMALIZING AMINO ACID METABOLISM
    Publication number: 20200069624
    Abstract: Methods of normalizing amino acid metabolism in subjects on restricted protein diets and supplemental amino acids, using specially formulated amino acids that mimic the absorption and metabolism of naturally occurring proteins, are described.
    Type: Application
    Filed: August 16, 2019
    Publication date: March 5, 2020
    Inventors: Alberto Reiner, Giorgio Reiner
  • Modified release orally administered amino acid formulations
    Patent number: 10500180
    Abstract: Methods and formulations of modified release amino acids are provided for the treatment or management of diseases defined by impaired amino acid metabolism, with improved pharmacokinetics, metabolism and utilization.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: December 10, 2019
    Assignee: APR Applied Pharma Research S.A.
    Inventors: Alberto Reiner, Giorgio Reiner
  • MODIFIED RELEASE ORALLY ADMINISTERED AMINO ACID FORMULATIONS
    Publication number: 20180318244
    Abstract: Methods and formulations of modified release amino acids are provided for the treatment or management of diseases defined by impaired amino acid metabolism, with improved pharmacokinetics, metabolism and utilization.
    Type: Application
    Filed: March 28, 2018
    Publication date: November 8, 2018
    Applicant: APR Applied Pharma Research S.A.
    Inventors: Alberto REINER, Giorgio REINER
  • MODIFIED RELEASE ORALLY ADMINISTERED AMINO ACID FORMULATIONS
    Publication number: 20180185311
    Abstract: Methods and formulations of modified release amino acids are provided for the treatment or management of diseases defined by impaired amino acid metabolism, with improved pharmacokinetics, metabolism and utilization.
    Type: Application
    Filed: September 27, 2016
    Publication date: July 5, 2018
    Applicant: APR Applied Pharma Research S.A.
    Inventors: Alberto REINER, Giorgio REINER
  • Diclofenac formulations and methods of use
    Patent number: 9827197
    Abstract: Methods and formulations are provided for treating migraine and other acute pain episodes using diclofenac, and formulations of diclofenac that provide both rapid and sustained relief from acute pain. Methods and formulations are also provided for treating symptoms that often accompany migraine and acute pain such as photophobia, phonophobia, nausea and vomiting.
    Type: Grant
    Filed: November 6, 2014
    Date of Patent: November 28, 2017
    Assignee: APR APPLIED PHARMA RESEARCH SA
    Inventors: Giorgio Reiner, Alberto Reiner, Andreas Meyer
  • DICLOFENAC FORMULATIONS AND METHODS OF USE
    Publication number: 20170319484
    Abstract: Methods and formulations are provided for treating migraine and other acute pain episodes using diclofenac, and formulations of diclofenac that provide both rapid and sustained relief from acute pain. Methods and formulations are also provided for treating symptoms that often accompany migraine and acute pain such as photophobia, phonophobia, nausea and vomiting.
    Type: Application
    Filed: May 24, 2017
    Publication date: November 9, 2017
    Inventors: Giorgio Reiner, Alberto Reiner
  • DICLOFENAC FORMULATIONS AND METHODS OF USE
    Publication number: 20150064258
    Abstract: Methods and formulations are provided for treating migraine and other acute pain episodes using diclofenac, and formulations of diclofenac that provide both rapid and sustained relief from acute pain. Methods and formulations are also provided for treating symptoms that often accompany migraine and acute pain such as photophobia, phonophobia, nausea and vomiting.
    Type: Application
    Filed: November 6, 2014
    Publication date: March 5, 2015
    Applicant: APR Applied Pharma Research s.a.
    Inventors: Giorgio Reiner, Alberto Reiner, Andreas Meyer
  • Diclofenac formulations and methods of use
    Patent number: 8927604
    Abstract: Methods and formulations are provided for treating migraine and other acute pain episodes using diclofenac, and formulations of diclofenac that provide both rapid and sustained relief from acute pain. Methods and formulations are also provided for treating symptoms that often accompany migraine and acute pain such as photophobia, phonophobia, nausea and vomiting.
    Type: Grant
    Filed: January 16, 2013
    Date of Patent: January 6, 2015
    Assignee: APR Applied Pharma Research s.a.
    Inventors: Giorgio Reiner, Alberto Reiner